YPS

Ypsomed Hldg Stock

StockStock
ISIN: CH0019396990
Ticker: YPSN
CH0019396990
YPSN

Price

Historical dividends and forecast

All dividend data

Ypsomed Hldg has so far distributed $3.325 in 2024. The next dividend will be paid on 02.07.2025


$1.129

CHART BY

Frequently asked questions

What is Ypsomed Hldg's market capitalization?

The market capitalization of Ypsomed Hldg is $5.83B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Ypsomed Hldg's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Ypsomed Hldg is 69.74. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Ypsomed Hldg?

Ypsomed Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.126. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Ypsomed Hldg's stock?

Currently, 3 analysts cover Ypsomed Hldg's stock, with a consensus target price of $424.96. Analyst ratings provide insights into the stock's expected performance.

What is Ypsomed Hldg's revenue over the trailing twelve months?

Over the trailing twelve months, Ypsomed Hldg reported a revenue of $693.73M.

What is the EBITDA for Ypsomed Hldg?

Ypsomed Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $183.66M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Ypsomed Hldg?

Ypsomed Hldg has a free cash flow of -$128.09M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Ypsomed Hldg's stock?

The 5-year beta for Ypsomed Hldg is 1.34. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Ypsomed Hldg have, and what sector and industry does it belong to?

Ypsomed Hldg employs approximately 2,600 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Ypsomed Hldg's shares?

The free float of Ypsomed Hldg is 3.83M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$5.83B

5Y beta

 
1.34

EPS (TTM)

 
$6.126

Free Float

 
3.83M

P/E ratio (TTM)

 
69.74

Revenue (TTM)

 
$693.73M

EBITDA (TTM)

 
$183.66M

Free Cashflow (TTM)

 
-$128.09M

Pricing

1D span
$425.83$461.33

Analyst Ratings

The price target is $424.96 and the stock is covered by 3 analysts.

Buy

2

Hold

0

Sell

1

Information

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.

2,600

Medical Equipment & Supplies

Health Care

Identifier

ISIN

CH0019396990

Primary Ticker

YPSN

Knockouts

Join the conversation